New antibiotic drug is a ‘massive game changer’ for people with chronic lower back pain
Early clinical trial results suggest that a groundbreaking new antibiotic drug could be a “massive game changer” for some patients suffering from chronic lower back pain.
Study exposes huge levels of untargeted antibiotic prescribing
Doctors are prescribing antibiotics for tens of thousands of patients with infections, with little or no consideration of ...
Verywell Health on MSN4d
A New FDA-Approved Antibiotic May Help Women With Recurring UTIs
If you deal with recurrent UTIs, a new FDA-approved antibiotic called Blujepa could offer another treatment option—especially ...
FDA approves first new antibiotic for UTIs in nearly 30 years
The drug Blujepa, from drugmaker GSK, provides a new treatment option as bacteria increasingly become resistant to the ...
Scripps News10d
FDA approves first new antibiotic treatment for UTIs in decades
A new antibiotic has been approved to treat urinary tract infections by the Food and Drug Administration for the first time ...
Everyday Health on MSN9d
New UTI Antibiotic Is the First Approved by the FDA in Nearly 30 Years
Key TakeawaysBlujepa (gepotidacin) is the first new antibiotic class approved in nearly 30 years, providing a crucial ...